ZEVRA THERAPEUTICS, INC. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Zevra Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Zevra Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 223 %, a 68.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 223 -487 -68.6% Jun 30, 2024
Q1 2024 272 -583 -68.2% Mar 31, 2024
Q4 2023 334 -881 -72.5% Dec 31, 2023
Q3 2023 647 -1.08K -62.5% Sep 30, 2023
Q2 2023 710 -1.75K -71.1% Jun 30, 2023
Q1 2023 855 -2.07K -70.7% Mar 31, 2023
Q4 2022 1.21K -1.4K -53.5% Dec 31, 2022
Q3 2022 1.73K +16 +0.94% Sep 30, 2022
Q2 2022 2.46K +2.18K +804% Jun 30, 2022
Q1 2022 2.92K +2.85K +3898% Mar 31, 2022
Q4 2021 2.61K +2.6K +18924% Dec 31, 2021
Q3 2021 1.71K +1.7K +12836% Sep 30, 2021
Q2 2021 272 +253 +1373% Jun 30, 2021
Q1 2021 73.1 +45 +161% Mar 31, 2021
Q4 2020 13.7 -72.4 -84.1% Dec 31, 2020
Q3 2020 13.2 -94 -87.7% Sep 30, 2020
Q2 2020 18.4 -88.1 -82.7% Jun 30, 2020
Q1 2020 28 -109 -79.6% Mar 31, 2020
Q4 2019 86.1 -92.8 -51.9% Dec 31, 2019
Q3 2019 107 -109 -50.5% Sep 30, 2019
Q2 2019 107 -229 -68.2% Jun 30, 2019
Q1 2019 137 -357 -72.2% Mar 31, 2019
Q4 2018 179 -547 -75.3% Dec 31, 2018
Q3 2018 217 -767 -78% Sep 30, 2018
Q2 2018 335 -751 -69.2% Jun 30, 2018
Q1 2018 494 -676 -57.8% Mar 31, 2018
Q4 2017 726 -586 -44.7% Dec 31, 2017
Q3 2017 984 -172 -14.9% Sep 30, 2017
Q2 2017 1.09K -4.97 -0.46% Jun 30, 2017
Q1 2017 1.17K +50.3 +4.49% Mar 31, 2017
Q4 2016 1.31K +527 +67.2% Dec 31, 2016
Q3 2016 1.16K +418 +56.7% Sep 30, 2016
Q2 2016 1.09K Jun 30, 2016
Q1 2016 1.12K Mar 31, 2016
Q4 2015 784 Dec 31, 2015
Q3 2015 737 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.